Drug Shortage Report for MYLAN-MIRTAZAPINE

Last updated on 2025-02-25 History
Report ID 230092
Drug Identification Number 02256126
Brand name MYLAN-MIRTAZAPINE
Common or Proper name MIRTAZAPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) MIRTAZAPINE
Strength(s) 45MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-06-26
Actual start date 2024-06-26
Estimated end date 2025-02-20
Actual end date 2025-02-18
Shortage status Resolved
Updated date 2025-02-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2025-02-25 French Compare
v35 2025-02-25 English Compare
v34 2025-02-18 French Compare
v33 2025-02-18 English Compare
v32 2025-02-12 French Compare
v31 2025-02-12 English Compare
v30 2025-01-15 French Compare
v29 2025-01-15 English Compare
v28 2025-01-07 French Compare
v27 2025-01-07 English Compare
v26 2024-12-03 French Compare
v25 2024-12-03 English Compare
v24 2024-11-25 French Compare
v23 2024-11-25 English Compare
v22 2024-11-04 French Compare
v21 2024-11-04 English Compare
v20 2024-10-22 French Compare
v19 2024-10-22 English Compare
v18 2024-10-04 French Compare
v17 2024-10-04 English Compare

Showing 1 to 20 of 36